The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central role in our ability to understand and predict (neo-)antigen presentation in infectious diseases and cancer. Here, by exploiting co-occurrence of HLA-I alleles across ten newly generated as well as forty public HLA peptidomics datasets comprising more than 115,000 unique peptides, we show that we can rapidly and accurately identify many HLA-I binding motifs and map them to their corresponding alleles without any a priori knowledge of HLA-I binding specificity. Our approach recapitulates and refines known motifs for 43 of the most frequent alleles, uncovers new motifs for 9 alleles that up to now had less than five known ligands and provides a...
Binding of peptides to Major Histocompatibility Complex (MHC) molecules is the single most selective...
HLA class I molecules reflect the health state of cells to cytotoxic T cells by presenting a reperto...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...
<div><p>The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
The remarkable clinical efficacy of the immune checkpoint blockade therapies has motivated researche...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central ro...
The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central ro...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
HLA-I molecules bind short peptides and present them for recognition by CD8 <sup>+</sup>...
Binding of peptides to Major Histocompatibility Complex (MHC) molecules is the single most selective...
HLA class I molecules reflect the health state of cells to cytotoxic T cells by presenting a reperto...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...
<div><p>The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
The remarkable clinical efficacy of the immune checkpoint blockade therapies has motivated researche...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central ro...
The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central ro...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
HLA-I molecules bind short peptides and present them for recognition by CD8 <sup>+</sup>...
Binding of peptides to Major Histocompatibility Complex (MHC) molecules is the single most selective...
HLA class I molecules reflect the health state of cells to cytotoxic T cells by presenting a reperto...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...